The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of Salmonella typhimurium
Abstract
VNP20009 is a genetically modified strain of Salmonella typhimurium possessing an excellent safety profile, including genetically stable attenuated virulence (a deletion in the purI gene), reduction of septic shock potential (a deletion in the msbB gene), and antibiotic susceptibility. VNP20009 is genetically stable after multiple generations in vitro and in vivo. In mice, VNP20009 is rapidly cleared from the blood from a peak level of 1x104 cfu/mL to undetectable levels in 24 h. In tumor-bearing mice, VNP20009 accumulates preferentially in tumors over livers at a ratio of 1000&rcolon;1. In nonhuman primates, VNP20009 was also rapidly cleared from the blood, from a peak level of 1.0x106 cfu/mL to undetectable levels in 24 h. VNP20009 was detected in the liver, spleen, and bone marrow of monkeys; the amount decreased over time, and VNP20009 was cleared from all organs by day 41; no VNP20009 could be detected in the urine or feces of the monkeys. VNP20009 is genetically stable after many generations of growth (>140) both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Positive selection for loss of tetracycline resistance
Bochner, B. R., Huang, H. C., Schieven, G. L., & Ames, B. N. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.926-933.1980 · Cited by 695
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Self-citationLow, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 476
Self-citationRegulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
Salmonella spp. are cytotoxic for cultured macrophages
Chen, L. M., Kaniga, K., & Galán, J. E. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.471410.x · Cited by 379
Nauts, H. C., Swift, W. E., & Coley, B. L. (1946) · PubMed · Cited by 346
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.579 · Cited by 230
Self-citationA lethal role for lipid A in Salmonella infections
Khan, S. A., Everest, P., Servos, S., Foxwell, N., Zähringer, U., Brade, H., Rietschel, E. T., Dougan, G., Charles, I. G., & Maskell, D. J. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00952.x · Cited by 212
Hardt, W.-D., Urlaub, H., & Galán, J. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2574 · Cited by 211
Clementz, T., Zhou, Z., & Raetz, C. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10353 · Cited by 199
Tumour progression and survival in patients with T1G3 bladder tumours: 15‐year outcome
HERR, H. W. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.00431.x · Cited by 171
Karow, M. L., & Georgopoulos, C. P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.3.702-710.1992 · Cited by 109
Carey, R. W., Holland, J. F., Whang, H. Y., Neter, E., & Bryant, B. (1967) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(67)90060-6 · Cited by 104
Jackson, A. M., Ivshina, A. V., Sen'ko, O. V., Kuznetsova, A. V., Sundan, A., O’Donnell, M. A., Clinton, S. K., ALEXANDROFF, A. B., Selby, P. J., James, K., et al. (1998) · PubMed · Cited by 48
Liu, M., Bryant, M., Chen, J., Lee, S., Yaremko, B., Li, Z., Dell, J., Lipari, P., Malkowski, M. G., Prioli, N. A., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050862 · Cited by 41
Self-citationInfection of a Secondary Carcinoma by Salmonella montevideo
Graham, F., & Coleman, P. N. (1952) · BMJ · doi:10.1136/bmj.1.4768.1116 · Cited by 29
Cited by
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Self-citationToso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Combination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Metadata
- Authors
- Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., Li, Z., Luo, X., King, I., & Zheng, L. M.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06
- Volume
- 181
- Issue
- 6
- Pages
- 1996-2002
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2115205513
- Cited by
- 355
- References
- 20
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.